Table 2. vWF and Propeptide Levels in... | American Society of Hematology

Table 2.

vWF and Propeptide Levels in Patients With Vascular Disease

Patient	vWF (mature) (nmol/L ± SEM)	Propeptide (nmol/L ± SEM)	No. of Patients
Chronic diabetes mellitus	94.5 ± 6.4^‡	8.0 ± 0.4 (NS)	22
Acute TTP	112.7 ± 16.6^‡	17.3 ± 3.3^†	13
Sepsis	127.8 ± 14.7^‡	17.8 ± 2.3^‡	14
Controls^*	54.2 ± 6.0	7.1 ± 0.7	18

Patient	vWF (mature) (nmol/L ± SEM)	Propeptide (nmol/L ± SEM)	No. of Patients
Chronic diabetes mellitus	94.5 ± 6.4^‡	8.0 ± 0.4 (NS)	22
Acute TTP	112.7 ± 16.6^‡	17.3 ± 3.3^†	13
Sepsis	127.8 ± 14.7^‡	17.8 ± 2.3^‡	14
Controls^*	54.2 ± 6.0	7.1 ± 0.7	18

Abbreviation: NS, not significant.

Patients without vascular disease admitted to the hospital. vWF and propeptide levels of patients with vascular pathology were compared with this control group.

†

P < .01.

‡

P < .001.

View Large

This Feature Is Available To Subscribers Only